I am a neuroscientist specialized in molecular/cell biology, electrophysiology and pharmacology working in the field of drug addiction and mood disorders. I study the neuroadaptations that occur in particular areas of the brain (mesocorticolimbic system) after drug exposure, and the behavioral expression of such adaptations. I specifically focus in the plasticity of the inhibitory signaling regulated by G protein coupled receptors (GPCRs) and G protein activated inwardly rectifying potassium (GIRK) channels. I am also interested in exploiting the pharmacological regulation of GIRK channels as they could be promising targets for the treatment of addiction as well as other diseases where GIRK channels seem to be involved, such as autism/ADHD, Down syndrome, Schizophrenia, Parkinson, and Alzheimer disease.
As Manager of the Viral Vector and Cloning Core and the Viral Innovation Core, I have developed strong connections with many investigators at the University of Minnesota (and outside), including those in the field of drug addiction. I provide guidance to VVCC/VIC customers with viral vector design, production and use, as well as support related to their manuscript and grant applications.
